Skip to main content

Supplementary Table S2 from Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib

Publication ,  Other
Rosen, E; Yap, TA; Lee, EK; Højgaard, M; Mettu, NB; Lheureux, S; Carneiro, BA; Plummer, R; Fretland, AJ; Ulanet, D; Xu, Y; McDougall, R ...
February 16, 2024

<p>Supplementary Table S2. Representativeness of study participants.</p>

Duke Scholars

DOI

Publication Date

February 16, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rosen, E., Yap, T. A., Lee, E. K., Højgaard, M., Mettu, N. B., Lheureux, S., … Fontana, E. (2024). Supplementary Table S2 from Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib. https://doi.org/10.1158/1078-0432.25232388
Rosen, Ezra, Timothy A. Yap, Elizabeth K. Lee, Martin Højgaard, Niharika B. Mettu, Stephanie Lheureux, Benedito A. Carneiro, et al. “Supplementary Table S2 from Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib,” February 16, 2024. https://doi.org/10.1158/1078-0432.25232388.
Rosen E, Yap TA, Lee EK, Højgaard M, Mettu NB, Lheureux S, Carneiro BA, Plummer R, Fretland AJ, Ulanet D, Xu Y, McDougall R, Koehler M, Fontana E. Supplementary Table S2 from Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib. 2024.

DOI

Publication Date

February 16, 2024